Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

CellaVision AB (publ) (C26.F)

16.80
+2.28
+(15.70%)
At close: April 29 at 9:13:34 AM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D. Founder & Director 285k -- 1965
Mr. Simon Ostergaard Ph.D. CEO & President -- -- 1971
Mr. Magnus Blixt Chief Financial Officer -- -- 1966
Ms. Helena Raihle Corporate Communications & Investor Relations -- -- --
Mr. Peter Wilson Vice President of Business Development & Global Marketing -- -- 1967
Mr. Urban Strindlov Vice President of Global Sales -- -- 1964
Ms. Elin Bredberg Vice President of Human Resource -- -- 1979

CellaVision AB (publ)

MobilvAegen 12
Lund, 223 62
Sweden
46 4 64 60 16 00 https://www.cellavision.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
219

Description

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers, instruments; and hardware products include in vitro diagnostics IVD for laboratories; as well as its portfolio includes smear makers, stainers, stains, and staining protocols; DIFF-Line is a hematology lab that handles a smaller amount daily blood samples and consists three instruments for smearing, staining, and analyzing peripheral blood smears CellaVision DC-1, RAL SmearBox, and RAL StainBox. It also provides CellaVision DC-1 for performing blood cell differentials; CellaVision DM1200 and CellaVision DM9600 are designed to automate and simplify the process of performing blood and body fluid differentials. In addition, its CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

Corporate Governance

CellaVision AB (publ)’s ISS Governance QualityScore as of April 1, 2025 is 4. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 1; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 7, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 17, 2025 at 5:20 AM UTC

CellaVision AB (publ) Earnings Date

Recent Events